Early clinical experience with imatinib in COVID-19: Searching for a dual effect - 25/04/21
Highlights |
• | Imatinib has shown antiviral and immunomodulatory properties in preclinical models. |
• | Imatinib could potentially be helpful in COVID-19. |
• | This is the first case series of COVID-19 patients treated with imatinib. |
• | Imatinib is a well-known drug whose safety profile seems acceptable in COVID-19. |
Graphical abstract |
Plan
Vol 82 - N° 5
P. 186-230 - mai 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.